Kazia Therapeutics Aktie - KZIA

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

3,44

Gebot

3,46

Fragen

3,66

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Marktkapitalisierung

4,677M

Handelsende

3,44

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

Ausgegebene Aktien

1.359.625

Dividendenrendite

Kurs-Gewinn-Verhältnis

0,00

Gewinn pro Aktie (EPS)

-20,09

Erlöse

2,31M

Nettogewinn

-27,32M

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.kaziatherapeutics.com

Hauptsitz

Sydney, New South Wales, Aus

Gegründet

Kazia Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KZIA. The last closing price for Kazia Therapeutics was US$3,44. Over the last year, Kazia Therapeutics shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Kazia Therapeutics currently has 1.359.625 shares in issue. The market capitalisation of Kazia Therapeutics is US$4,68 million. Kazia Therapeutics has a price to earnings ratio (PE ratio) of 0.00.

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

KZIA - Frequently Asked Questions (FAQ)

What is the current Kazia Therapeutics share price?

The current share price of Kazia Therapeutics is US$ 3,44

How many Kazia Therapeutics shares are in issue?

Kazia Therapeutics has 1.359.625 shares in issue

What is the market cap of Kazia Therapeutics?

The market capitalisation of Kazia Therapeutics is USD 4,68M

What is the 1 year trading range for Kazia Therapeutics share price?

Kazia Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year

What is the cash to sales ratio of Kazia Therapeutics?

The cash to sales ratio of Kazia Therapeutics is 0,05

What is the reporting currency for Kazia Therapeutics?

Kazia Therapeutics reports financial results in AUD

What is the latest annual turnover for Kazia Therapeutics?

The latest annual turnover of Kazia Therapeutics is AUD 2,31M

What is the latest annual profit for Kazia Therapeutics?

The latest annual profit of Kazia Therapeutics is AUD -27,32M

What is the registered address of Kazia Therapeutics?

The registered address for Kazia Therapeutics is THREE INTERNATIONAL TOWERS, LEVEL 24, 300 BARANGAROO TOWERS, SYDNEY, NEW SOUTH WALES, 2000

What is the Kazia Therapeutics website address?

The website address for Kazia Therapeutics is www.kaziatherapeutics.com

Which industry sector does Kazia Therapeutics operate in?

Kazia Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
AGMHAGM Group Holdings Inc	US$ 0,067 (123,33%)	159,99M
SNOASonoma Pharmaceuticals Inc	US$ 4,74 (103,43%)	29,25M
DSGNDesign Therapeutics Inc	US$ 6,09 (53,79%)	56
FUSBFirst US Bancshares Inc	US$ 19,00 (51,52%)	1
AGRIAgriFORCE Growing Systems Ltd	US$ 2,10 (45,47%)	23,46M
FORAForian Inc	US$ 1,06 (-45,08%)	3
TBLDThomburg Income Builder Opportunities Trust	US$ 10,01 (-42,90%)	22
FONRFonar Corporation	US$ 9,01 (-25,38%)	5
BSCVInvesco BulletShares 2031 Corporate Bond ETF	US$ 12,11 (-24,74%)	1
MRINMarin Software Incorporated	US$ 0,6238 (-24,45%)	61,77k
AGMHAGM Group Holdings Inc	US$ 0,067 (123,33%)	159,99M
BTOGBit Origin Ltd	US$ 0,188 (43,18%)	73,77M
DMNDamon Inc	US$ 0,004 (2,56%)	36,17M
SNOASonoma Pharmaceuticals Inc	US$ 4,74 (103,43%)	29,25M
AGRIAgriFORCE Growing Systems Ltd	US$ 2,10 (45,47%)	23,46M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Kazia Therapeutics Ltd (KZIA)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Kazia Therapeutics Ltd

KZIA Neueste Nachrichten

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Kazia Therapeutics Announces Sale of Intellectual Property and Trademarks Rights for Cantrixil

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

KZIA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Kazia Therapeutics Ltd (KZIA) Börsenkurse

Kazia Therapeutics Ltd (KZIA)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Über Kazia Therapeutics Ltd

KZIA Neueste Nachrichten

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Kazia Therapeutics Announces Sale of Intellectual Property and Trademarks Rights for Cantrixil

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

KZIA - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR